Decoy Therapeutics, Inc. (DCOY)

2.73 -0.15 (-5.21%) USD  |  NASDAQ  |  Sep 04, 13:50
More

Decoy Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for DCOY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Total Expenses (% of Annual Revenues) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2021 --
December 31, 2020 --
December 31, 2019 --
Date Value
December 31, 2018 --
December 31, 2017 --
December 31, 2016 --

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Palatin Technologies, Inc. --
Unicycive Therapeutics, Inc. --
Nuvectis Pharma, Inc. --
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade